Page last updated: 2024-08-24

ziprasidone and Callous-Unemotional Traits

ziprasidone has been researched along with Callous-Unemotional Traits in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Biederman, J; Cook, E; DiSalvo, M; Faraone, SV; Farrell, A; Joshi, G; Wozniak, J; Yule, A1
Hetrick, SE; Loy, JH; Merry, SN; Stasiak, K1
Connolly, JG; Schneeweiss, MC; Toomey, TJ1
Canive, JM; Khan, A; Lieberman, JA; McEvoy, JP; McGee, M; Miller, DD; Reimherr, F; Rosenheck, RA; Stroup, TS; Swanson, JW; Swartz, MS; Van Dorn, R; Wagner, HR1

Reviews

1 review(s) available for ziprasidone and Callous-Unemotional Traits

ArticleYear
Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    The Cochrane database of systematic reviews, 2017, 08-09, Volume: 8

    Topics: Adolescent; Aggression; Antipsychotic Agents; Anxiety Disorders; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Conduct Disorder; Depressive Disorder, Major; Dibenzothiazepines; Humans; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Thiazoles; Weight Gain

2017

Other Studies

3 other study(ies) available for ziprasidone and Callous-Unemotional Traits

ArticleYear
Can pediatric bipolar disorder be successfully treated when comorbid with conduct disorder? A secondary analysis of clinical trials of risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole.
    Journal of psychopharmacology (Oxford, England), 2022, Volume: 36, Issue:5

    Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Child; Clinical Trials as Topic; Conduct Disorder; Humans; Mania; Olanzapine; Piperazines; Prospective Studies; Quetiapine Fumarate; Risperidone; Thiazoles

2022
Metabolic monitoring for youths initiating use of second-generation antipsychotics, 2003-2011.
    Psychiatric services (Washington, D.C.), 2015, Volume: 66, Issue:6

    Topics: Adolescent; Affective Disorders, Psychotic; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Blood Glucose; Child; Child, Preschool; Cohort Studies; Conduct Disorder; Databases, Factual; Depressive Disorder; Diabetes Mellitus; Female; Glycated Hemoglobin; Guideline Adherence; Humans; Hyperkinesis; Male; Mass Screening; Mental Disorders; Olanzapine; Piperazines; Practice Guidelines as Topic; Practice Patterns, Physicians'; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risperidone; Thiazoles

2015
Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study.
    The Journal of nervous and mental disease, 2006, Volume: 194, Issue:3

    Topics: Antipsychotic Agents; Comorbidity; Conduct Disorder; Cross-Sectional Studies; Diagnosis, Dual (Psychiatry); Double-Blind Method; Female; Humans; Male; Multicenter Studies as Topic; Piperazines; Prevalence; Randomized Controlled Trials as Topic; Risk Factors; Schizophrenia; Schizophrenic Psychology; Sex Factors; Substance-Related Disorders; Thiazoles; Treatment Outcome; United States

2006